Coronavirus (COVID-19)

Takeda recognizes the immense concern related to COVID-19, and we are here to support our ADHD patients during this time

Patient safety is Takeda’s highest priority. As a company, we are committed to taking steps to keep the communities we serve updated with any new information that could help inform health decisions related to our medicines.

If your teen (13+) is currently taking Mydayis, we strongly encourage you to stay in contact with your healthcare provider and to make use of any virtual or remote services that may be offered. You may also call our Medical Information Line at 1-800-828-2088 for questions regarding your teen’s medication.

For information on savings and paying for your teen’s medication, please click here.

For the latest updates and news about Takeda and COVID-19, including information about the supply of Mydayis, please click here.

For Patients 13+ with ADHD, the following resources may provide further helpful information during this time: